Linagliptin impurity N

Linagliptin impurity N is a structurally related synthetic byproduct arising from incomplete alkylation during the formation of the tetrahydropyridine core in the parent drug. It retains the pyrazine-naphthalene scaffold but lacks the N-methyl substitution at the piperidine nitrogen, presenting a secondary amine functionality. This structural deviation results in altered HPLC retention and reduced DPP-4 inhibitory activity. The compound serves as a critical reference standard for quantitative impurity profiling in quality control of linagliptin APIs.